[1]
|
Chalasani, N., Younossi, Z., Lavine, J.E., et al. (2018) The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance from the American Association for the Study of Liver Diseases. Hepatology, 1, 328-357.
https://doi.org/10.1002/hep.29367
|
[2]
|
Powell, E.E., Wong, V.W. and Rinella, M. (2021) Non-Alcoholic Fatty Liver Dis-ease. The Lancet, 397, 2212-2224.
https://doi.org/10.1016/S0140-6736(20)32511-3
|
[3]
|
Zhou, F., Zhou, J., Wang, W., et al. (2019) Unexpected Rapid In-crease in the Burden of NAFLD in China from 2008 to 2018: A Systematic Review and Meta-Analysis. Hepatology, 70, 1119-1133. https://doi.org/10.1002/hep.30702
|
[4]
|
Lindenmeyer, C.C. and McCullough, A.J. (2018) The Natural History of Nonalcoholic Fatty Liver Disease—An Evolving View. Clinics in Liver Disease, 22, 11-21. https://doi.org/10.1016/j.cld.2017.08.003
|
[5]
|
Riazi, K., Azhari, H., Charette, J.H., et al. (2022) The Prevalence and Inci-dence of NAFLD Worldwide: A Systematic Review and Meta-Analysis. The Lancet Gastroenterology & Hepatology, 7, 851-861.
https://doi.org/10.1016/S2468-1253(22)00165-0
|
[6]
|
Fleming, K.A., Morton, J.A., Barbatis, C., et al. (1981) Mallory Bodies in Alcoholic and Non-Alcoholic Liver Disease Contain a Commonantigenic Determinant. Gut, 22, 341-344. https://doi.org/10.1136/gut.22.5.341
|
[7]
|
Day, C.P. and James, O.F.W. (1998) Steatohepatitis: A Tale of Two “Hits”? Gastroenterology, 114, 842-845.
https://doi.org/10.1016/S0016-5085(98)70599-2
|
[8]
|
Enooku, K., Kondo, M., Fujiwara, N., et al. (2018) Hepatic IRS1 and ß-Catenin Expression Is Associated with Histological Progressionand Overt Diabetes Emergence in NAFLD Patients. Journal of Gastroenterology, 53, 1261-1275.
https://doi.org/10.1007/s00535-018-1472-0
|
[9]
|
Softic, S., Boucher, J., Solheim, M.H., et al. (2016) Lipodystrophy Due to Adipose Tissue-Specific Insulin Receptor Knockout Results in Progressive NAFLD. Diabetes, 65, 2187-2200. https://doi.org/10.2337/db16-0213
|
[10]
|
Neuschwander-Tetri, B.A. (2010) Hepatic Lipotoxicity and the Pathogenesis of Nonalcoholic Steatohepatitis: The Central Role of Nontriglyceride Fatty Acid Metabolites. Hepatology, 52, 774-788. https://doi.org/10.1002/hep.23719
|
[11]
|
Lambert, J.E., Ramos Roman, M.A., Browning, J.D. and Parks, E.J. (2014) In-creased De Novo Lipogenesis Is a Distinct Characteristic of Individuals with Nonalcoholic Fatty Liver Disease. Gastroenterology, 146, 726-735.
https://doi.org/10.1053/j.gastro.2013.11.049
|
[12]
|
Jin, C.J., Engstler, A.J., Ziegenhardt, D., et al. (2017) Loss of Lipopoly-saccharide-Binding Protein Attenuates the Development of Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice. Journal of Gastroenterology and Hepatology, 32, 708-715. https://doi.org/10.1111/jgh.13488
|
[13]
|
Carpino, G., Del, B.M., Pastori, D., et al. (2020) Increased Liver Localization of Lipopolysaccharides in Human and Experimental NAFLD. Hepatology, 72, 470-485. https://doi.org/10.1002/hep.31056
|
[14]
|
Schuster, S., Cabrera, D., Arrese, M., et al. (2018) Triggering and Resolution of In-flammation in NASH. Nature Reviews Gastroenterology & Hepatology, 15, 349-364. https://doi.org/10.1038/s41575-018-0009-6
|
[15]
|
Davis, R.P., Surewaard, B.G.J., Turk, M., et al. (2019) Optimization of in vivo Imaging Provides a First Look at Mouse Model of Non-Alcoholic Fatty Liver Disease (NAFLD) Using Intravital Micros-copy. Frontiers in Immunology, 10, Article 2988. https://doi.org/10.3389/fimmu.2019.02988
|
[16]
|
Saviano, A., Henderson, N.C. and Baumert, T.F. (2020) Single-Cell Genomics and Spatial Transcriptomics: Discovery of Novel Cell States and Cellular Interactions in Liver Physiology and Disease Biology. Journal of Hepatology, 73, 1219-1230. https://doi.org/10.1016/j.jhep.2020.06.004
|
[17]
|
Wang, W., Zhao, J., Gui, W., et al. (2018) Tauroursodeoxycholic Acid In-hibits Intestinal Inflammation and Barrier Disruption in Mice with Non-Alcoholic Fatty Liver Disease. British Journal of Phar-macology, 175, 469-484.
https://doi.org/10.1111/bph.14095
|
[18]
|
Buzzetti, E., Pinzani, M. and Tsochatzis, E.A. (2016) The Multiple-Hit Pathogenesis of Non-Alcoholic Fatty Liver Disease (NAFLD). Metabolism, 65, 1038-1048. https://doi.org/10.1016/j.metabol.2015.12.012
|
[19]
|
Eslam, M., Sanyal, A.J., George, J., et al. (2020) MAFLD: A Consen-sus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease. Gastroenterology, 158, 1999-2014. https://doi.org/10.1053/j.gastro.2019.11.312
|
[20]
|
Seo, Y.S. and Shah, V.H. (2012) The Role of Gut-Liver Axis in the Pathogenesis of Liver Cirrhosis and Portal Hypertension. Clinical and Molecular Hepatology, 18, 337-346. https://doi.org/10.3350/cmh.2012.18.4.337
|
[21]
|
Kouichi, M. and Hirohide, O. (2014) Role of Gut Microbiota and Toll-Like Receptors in Nonalcoholic Fatty Liver Disease. World Journal of Gastroenterology, 20, 7381-7391. https://doi.org/10.3748/wjg.v20.i23.7381
|
[22]
|
蒋贤哲, 张博彦, 罗海玲, 等. 肠肝轴在动物营养代谢和免疫中的作用[J]. 生物技术通报, 2022, 38(7): 128-135.
|
[23]
|
Fujisaka, S., Watanabe, Y. and Tobe, K. (2022) The Gut Microbiome: A Core Regulator of Metabolism. Journal of Endocrinology, 256, e220111. https://doi.org/10.1530/JOE-22-0111
|
[24]
|
Donaldson, G.P., Ladinsky, M.S., Yu, K.B., et al. (2018) Gut Microbiota Utilize Immunoglobulin A for Mucosal Colonization. Science, 360, 795-800. https://doi.org/10.1126/science.aaq0926
|
[25]
|
Yajima, M., Karaki, S.I., Tsuruta, T., et al. (2016) Diversity of the Intestinal Microbiota Differently Affects Non-Neuronal and Atropine-Sensitive Ileal Contractile Responses to Short-Chain Fatty Acids Inmice. Biomedical Research, 37, 319-328. https://doi.org/10.2220/biomedres.37.319
|
[26]
|
Parada, V.D., De la Fuente, M.K., Landskron, G., et al. (2019) Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases. Frontiers in Immunology, 10, Article No. 277. https://doi.org/10.3389/fimmu.2019.01486
|
[27]
|
Agus, A., Planchais, J. and Sokol, H. (2018) Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease. Cell Host Microbe, 23, 716-724. https://doi.org/10.1016/j.chom.2018.05.003
|
[28]
|
De Vadder, F., Grasset, E., Manneras, H.L., et al. (2018) Gut Microbiota Regulates Maturation of the Adult Enteric Nervous System via Enteric Serotonin Networks. Proceedings of the National Academy of Sciences of the United States of America, 115, 6458-6463. https://doi.org/10.1073/pnas.1720017115
|
[29]
|
Fuchs, C., Claudel, T. and Trauner, M. (2013) Bile Acid-Mediated Control of Liver Triglycerides. Seminars in Liver Disease, 33, 330-342. https://doi.org/10.1055/s-0033-1358520
|
[30]
|
De Fabiani, E., Mitro, N., Gilardi, F., et al. (2003) Coordinated Control of Cholesterol Catabolism to Bile Acids and of Gluconeogenesis via a Novel Mechanism of Transcription Regulation Linked to the Fasted-to-Fed Cycle. Journal of Biological Chemistry, 278, 39124-39132. https://doi.org/10.1074/jbc.M305079200
|
[31]
|
Jiao, N., Baker, S.S., Chapa-Rodriguez, A., et al. (2018) Suppressed Hepatic Bile Acid Signalling Despite Elevated Production of Primaryand Secondary Bile Acids in NAFLD. Gut, 67, 1881-1891.
https://doi.org/10.1136/gutjnl-2017-314307
|
[32]
|
Plaza-Díaz, J., Solís-Urra, P., Rodríguez-Rodríguez, F., et al. (2020) The Gut Barrier, Intestinal Microbiota, and Liver Disease: Molecular Mechanisms and Strategies to Manage. International Journal of Molecular Sciences, 21, Article 8351. https://doi.org/10.3390/ijms21218351
|
[33]
|
Camilleri, M., Madsen, K., Spiller, R., Van Meerveld, B.G. and Vern, G.N. (2012) Intestinal Barrier Function in Health and Gastrointestinal Disease. Neurogastroen-terology & Motility, 24, 503-512.
https://doi.org/10.1111/j.1365-2982.2012.01921.x
|
[34]
|
Vancamelbeke, M. and Vermeire, S. (2017) The Intestinal Barrier: A Fundamental Role in Health and Disease. Expert Review of Gastroenterology & Hepatology, 11, 821-834. https://doi.org/10.1080/17474124.2017.1343143
|
[35]
|
Nalle, S.C. and Turner, J.R. (2015) Intestinal Barrier Loss as a Criti-cal Pathogenic Link between Inflammatory Bowel Disease and Graft-versus-Host Disease. Mucosal Immunology, 8, 720-730. https://doi.org/10.1038/mi.2015.40
|
[36]
|
Pelaseyed, T., Bergström, J.H., Gustafsson, J.K., et al. (2014) The Mucus and Mucins of the Goblet Cells and Enterocytes Provide the First Defense Line of the Gastrointestinal Tract and Interact with the Im-mune System. Immunological Reviews, 260, 8-20. https://doi.org/10.1111/imr.12182
|
[37]
|
Lievin-Le, M.V. and Servin, A.L. (2006) The Front Line of Enteric Host Defense against Unwelcome Intrusion of Harmful Microorganisms: Mucins, Antimicrobial Peptides, and Microbiota. Clinical Microbiology Reviews, 19, 315-337. https://doi.org/10.1128/CMR.19.2.315-337.2006
|
[38]
|
Ermund, A., Schütte, A., Johansson, M.E.V., Gustafsson, J.K. and Hansson, G.C. (2013) Studies of Mucus in Mouse Stomach, Small Intestine, and Colon. I. Gastrointestinal Mucus Layers Have Different Properties Depending on Location as well as over the Peyer’s Patches. American Journal of Physiology: Gastrointesti-nal and Liver Physiology, 305, G341-G347. https://doi.org/10.1152/ajpgi.00046.2013
|
[39]
|
Gunnar, C. and Hansson, M.E.J. (2010) The Inner of the Two Muc2 Mucin-Dependent Mucus Layers in Colon Is Devoid of Bacteria. Gut Microbes, 1, 51-54. https://doi.org/10.4161/gmic.1.1.10470
|
[40]
|
Salim, S.Y. and Soderholm, J.D. (2011) Importance of Disrupted Intestinal Barrier in Inflammatory Bowel Diseases. Inflammatory Bowel Diseases, 17, 362-381. https://doi.org/10.1002/ibd.21403
|
[41]
|
Turner, J.R. (2009) Intestinal Mucosal Barrier Function in Health and Disease. Na-ture Reviews Immunology, 9, 799-809. https://doi.org/10.1038/nri2653
|
[42]
|
Kurashima, Y. and Kiyono, H. (2017) Mucosal Ecological Network of Epithelium and Immune Cells for Gut Homeostasis and Tissue Healing. Annual Review of Immunology, 35, 119-147.
https://doi.org/10.1146/annurev-immunol-051116-052424
|
[43]
|
Suzuki, T. (2013) Regulation of Intestinal Epithelial Perme-ability by Tight Junctions. Cellular and Molecular Life Sciences, 70, 631-659. https://doi.org/10.1007/s00018-012-1070-x
|
[44]
|
Nekrasova, O. and Green, K.J. (2013) Desmosome Assembly and Dy-namics. Trends in Cell Biology, 23, 537-546.
https://doi.org/10.1016/j.tcb.2013.06.004
|
[45]
|
Groschwitz, K.R. and Hogan, S.P. (2009) Intestinal Barrier Function: Mo-lecular Regulation and Disease Pathogenesis. Journal of Allergy and Clinical Immunology, 124, 3-20. https://doi.org/10.1016/j.jaci.2009.05.038
|
[46]
|
Furuse, M., Fujita, K., Hiiragi, T., Fujimoto, K. and Tsukita, S. (1998) Clau-din-1 and -2: Novel Integral Membrane Proteins Localizing at Tight Junctions with No Sequence Similarity to Occludin. Journal of Cell Biology, 141, 1539-1550. https://doi.org/10.1083/jcb.141.7.1539
|
[47]
|
Berkes, J., Viswanathan, V.K., Savkovic, S.D. and Hecht, G. (2003) Intestinal Epithelial Responses to Enteric Pathogens: Effects on the Tight Junction Barrier, Ion Transport, and Inflammation. Gut, 52, 439-451.
https://doi.org/10.1136/gut.52.3.439
|
[48]
|
Furuse, M., Hirase, T., Itoh, M., et al. (1993) Occludin: A Novel Integral Mem-brane Protein Localizing at Tight Junctions. The Journal of Cell Biology, 123, 1777-1788. https://doi.org/10.1083/jcb.123.6.1777
|
[49]
|
Cereijido, M., Contreras, R.G., Flores-Benítez, D., et al. (2007) New Diseases Derived or Associated with the Tight Junction. Archives of Medical Research, 38, 465-478. https://doi.org/10.1016/j.arcmed.2007.02.003
|
[50]
|
Lynn, K.S., Peterson, R.J. and Koval, M. (2020) Ruffles and Spikes: Control of Tight Junction Morphology and Permeability by Claudins. Biochimica et Biophysica Acta (BBA)—Biomembranes, 1862, Article ID: 183339.
https://doi.org/10.1016/j.bbamem.2020.183339
|
[51]
|
Hermiston, M.L. and Gordon, J.I. (1995) In vivo Analysis of Cadherin Function in the Mouse Intestinal Epithelium: Essential Roles in Adhesion, Maintenance of Differentiation, and Regulation of Pro-grammed Cell Death. The Journal of Cell Biology, 129, 489-506. https://doi.org/10.1083/jcb.129.2.489
|
[52]
|
Chieppa, M., Rescigno, M., Huang. A.Y. and Germain, R.N. (2006) Dynamic Imaging of Dendritic Cell Extension into the Small Bowel Lu-men Inresponse to Epithelial Cell TLR Engagement. Journal of Experimental Medicine, 203, 2841-2852. https://doi.org/10.1084/jem.20061884
|
[53]
|
Rescigno, M., Urbano, M., Valzasina, B., et al. (2001) Dendritic Cells Express Tight Junction Proteins and Penetrate Gut Epithelial Monolayers to Sample Bacteria. Nature Immunology, 2, 361-367. https://doi.org/10.1038/86373
|
[54]
|
McDonald, B.D., Jabri, B. and Bendelac, A. (2018) Diverse Developmental Pathways of Intestinal Intraepithelial Lymphocytes. Nature Reviews Immunology, 18, 514-525. https://doi.org/10.1038/s41577-018-0013-7
|
[55]
|
Burcelin, R. (2016) Gut Microbiota and Immune Crosstalk in Metabolic Disease. Molecular Metabolism, 5, 771-781.
https://doi.org/10.1016/j.molmet.2016.05.016
|
[56]
|
Mazzini, E., Massimiliano, L., Penna, G. and Rescigno, M. (2014) Oral Tolerance Can Be Established via Gap Junction Transfer of Fed Antigens from CX3CR1+ Macrophages to CD103+ Dendritic Cells. Immunity, 40, 248-261.
https://doi.org/10.1016/j.immuni.2013.12.012
|
[57]
|
Niess, J.H., Brand, S., Gu, X., et al. (2005) CX3CR1-Mediated Den-dritic Cell Access to the Intestinal Lumen and Bacterial Clearance. Science, 307, 254-258. https://doi.org/10.1126/science.1102901
|
[58]
|
Corbett, A.J., Eckle, S.B., Birkinshaw, R.W., et al. (2014) T-Cell Activation by Transitory Neo-Antigens Derived from Distinct Microbial Pathways. Nature, 509, 361-365. https://doi.org/10.1038/nature13160
|
[59]
|
Gomes, A.C., Hoffmann, C. and Mota, J.F. (2018) The Human Gut Microbiota: Metabolism and Perspective in Obesity. Gut Microbes, 9, 308-325. https://doi.org/10.1080/19490976.2018.1465157
|
[60]
|
Qin, J., Li, R., Raes, J., et al. (2010) A Human Gut Microbial Gene Catalogue Established by Metagenomic Sequencing. Nature, 464, 59-65. https://doi.org/10.1038/nature08821
|
[61]
|
Lee, M. and Chang, E.B. (2021) Inflammatory Bowel Diseases (IBD) and the Microbiome-Searching the Crime Scenefor Clues. Gastro-enterology, 160, 524-537. https://doi.org/10.1053/j.gastro.2020.09.056
|
[62]
|
Luis, A.S., Jin, C., Pereira, G.V., et al. (2021) A Single Sulfatase Is Required to Access Colonic Mucin by a Gut Bacterium. Nature, 598, 332-337. https://doi.org/10.1038/s41586-021-03967-5
|
[63]
|
Ouwerkerk, J.P., de Vos, W.M. and Belzer, C. (2013) Glycobiome: Bac-teria and Mucus at the Epithelial Interface. Best Practice & Research Clinical Gastroenterology, 27, 25-38. https://doi.org/10.1016/j.bpg.2013.03.001
|
[64]
|
Birchenough, G., Schroeder, B.O., Backhed, F. and Hansson, G.C. (2019) Dietary Destabilisation of the Balance between the Microbiota and the Colonicmucus Barrier. Gut Microbes, 10, 246-250.
https://doi.org/10.1080/19490976.2018.1513765
|
[65]
|
Schütte, A., Ermund, A., Becker-Pauly, C., et al. (2014) Microbi-al-Induced meprin β Cleavage in MUC2 Mucin and a Functional CFTR Channel Are Required to Release Anchored Small Intes-tinal Mucus. Proceedings of the National Academy of Sciences of the United States of America, 111, 12396-12401. https://doi.org/10.1073/pnas.1407597111
|
[66]
|
Rodriguez-Pineiro, A.M. and Johansson, M.E. (2015) The Colonic Mucus Protection Depends on the Microbiota. Gut Microbes, 6, 326-330. https://doi.org/10.1080/19490976.2015.1086057
|
[67]
|
Jakobsson, H.E., Rodriguez-Pineiro, A.M., Schutte, A., et al. (2015) The Composition of the Gut Microbiota Shapes the Colon Mucus Barrier. EMBO Reports, 16, 164-177. https://doi.org/10.15252/embr.201439263
|
[68]
|
Tashiro, M., Iwata, A., Yamauchi, M., et al. (2017) The N-Terminal Region of Serum Amyloid A3 Protein Activates NF-κB and up-Regulates MUC2 Mucin mRNA Expression in Mouse Colonic Epithelial Cells. PLOS ONE, 12, e181796. https://doi.org/10.1371/journal.pone.0181796
|
[69]
|
Cheng, D. and Xie, M.Z. (2021) A Re-view of a Potential and Promising Probiotic Candidate—Akkermansia muciniphila. Journal of Applied Microbiology, 130, 1813-1822. https://doi.org/10.1111/jam.14911
|
[70]
|
Liang, L., Liu, L., Zhou, W., et al. (2022) Gut Microbiota-Derived Bu-tyrate Regulates Gut Mucus Barrier Repair by Activating the Macrophage/WNT/ERK Signaling Pathway. Clinical Science, 136, 291-307.
https://doi.org/10.1042/CS20210778
|
[71]
|
Ijssennagger, N., Belzer, C., Hooiveld, G.J., et al. (2015) Gut Microbiota Facili-tates Dietary Heme-Induced Epithelial Hyperproliferation by Opening the Mucus Barrier in Colon. Proceedings of the National Academy of Sciences of the United States of America, 112, 10038-10043. https://doi.org/10.1073/pnas.1507645112
|
[72]
|
Rhee, K.J., Wu, S., Wu, X., et al. (2009) Induction of Persistent Colitis by a Human Commensal, Enterotoxigenic Bacteroides Fragilis, in Wild-Type C57BL/6 Mice. Infection and Immunity, 77, 1708-1718.
https://doi.org/10.1128/IAI.00814-08
|
[73]
|
Odenwald, M.A. and Turner, J.R. (2017) The Intestinal Epithelial Barrier: A Therapeutic Target? Nature Reviews Gastroenterology & Hepatology, 14, 9-21. https://doi.org/10.1038/nrgastro.2016.169
|
[74]
|
Martinez-Sanchez, L., Ngo, P.A., Pradhan, R., et al. (2023) Epithelial RAC1-Dependent Cytoskeleton Dynamics Controls Cell Mechanics, Cell Shedding and Barrier Integrity in Intestinal Inflamma-tion. Gut, 72, 275-294.
https://doi.org/10.1136/gutjnl-2021-325520
|
[75]
|
Zhou, J., Lin, H., Wang, Z., et al. (2020) Zinc L-Aspartate Enhances Intes-tinal Stem Cell Activity to Protect the Integrity of the Intestinal Mucosa against Deoxynivalenol through Activation of the Wnt/β-Catenin Signaling Pathway. Environmental Pollution, 262, Article ID: 114290. https://doi.org/10.1016/j.envpol.2020.114290
|
[76]
|
Hagi, T. and Belzer, C. (2021) The Interaction of Akkermansia mucini-phila with Host-Derived Substances, Bacteria and Diets. Applied Microbiology and Biotechnology, 105, 4833-4841. https://doi.org/10.1007/s00253-021-11362-3
|
[77]
|
Tsai, P., Zhang, B., He, W., et al. (2017) IL-22 Upregulates Epithelial Claudin-2 to Drive Diarrhea and Enteric Pathogen Clearance. Cell Host & Microbe, 21, 671-681.E4. https://doi.org/10.1016/j.chom.2017.05.009
|
[78]
|
Wang, R.X., Lee, J.S., Campbell, E.L. and Colgan, S.P. (2020) Microbio-ta-Derived Butyrate Dynamically Regulates Intestinal Homeostasis through Regulation of Actin-Associated Protein Synaptopodin. Proceedings of the National Academy of Sciences of the United States of America, 117, 11648-11657. https://doi.org/10.1073/pnas.1917597117
|
[79]
|
D’Alessandro, G., Antonangeli, F., Marrocco, F., et al. (2020) Gut Microbi-ota Alterations Affect Glioma Growth and Innate Immune Cells Involved in Tumor Immunosurveillance in Mice. European Journal of Immunology, 50, 705-711.
https://doi.org/10.1002/eji.201948354
|
[80]
|
Rubic, T., Lametschwandtner, G., Jost, S., et al. (2008) Triggering the Succinate Receptor GPR91 on Dendritic Cells Enhances Immunity. Nature Immunology, 9, 1261-1269. https://doi.org/10.1038/ni.1657
|
[81]
|
Olszak, T., An, D., Zeissig, S., et al. (2012) Microbial Exposure during Early Life Has Persistent Effects on Natural Killer T Cell Function. Science, 336, 489-493. https://doi.org/10.1126/science.1219328
|
[82]
|
Robertson, S.J., Goethel, A., Girardin, S.E. and Philpott, D.J. (2018) Innate Immune Influences on the Gut Microbiome: Lessons from Mouse Models. Trends in Immunology, 39, 992-1004. https://doi.org/10.1016/j.it.2018.10.004
|
[83]
|
Ivanov, I.I., Atarashi, K., Manel, N., et al. (2009) Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria. Cell, 139, 485-498. https://doi.org/10.1016/j.cell.2009.09.033
|
[84]
|
Sano, T., Huang, W., Hall, J.A., et al. (2015) An IL-23R/IL-22 Circuit Regulates Epithelial Serum Amyloid A to Promote Local Effector Th17 Responses. Cell, 163, 381-393. https://doi.org/10.1016/j.cell.2015.08.061
|
[85]
|
Levy, M., Kolodziejczyk, A.A., Thaiss, C.A. and Elinav, E. (2017) Dysbiosis and the Immune System. Nature Reviews Immunology, 17, 219-232. https://doi.org/10.1038/nri.2017.7
|
[86]
|
Pal, S., Saini, A.K., Kaushal, A., et al. (2022) The Colloquy between Microbiota and the Immune System in Colon Cancer: Repercussions on the Cancer Therapy. Current Pharmaceutical Design, 28, 3478-3485.
https://doi.org/10.2174/1381612829666221122115906
|
[87]
|
Atarashi, K., Tanoue, T., Shima, T., et al. (2011) Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species. Science, 331, 337-341. https://doi.org/10.1126/science.1198469
|
[88]
|
Campbell, C., McKenney, P.T., Konstantinovsky, D., et al. (2020) Bacterial Metabolism of Bile Acids Promotes Generation of Peripheral Regulatory T Cells. Nature, 581, 475-479. https://doi.org/10.1038/s41586-020-2193-0
|
[89]
|
Safari, Z. and Gérard, P. (2019) The Links between the Gut Microbiome and Non-Alcoholic Fatty Liver Disease (NAFLD). Cellular and Molecular Life Sciences, 76, 1541-1558. https://doi.org/10.1007/s00018-019-03011-w
|
[90]
|
Hoyles, L., Fernández-Real, J., Federici, M., et al. (2018) Molecular Phenomics and Metagenomics of Hepatic Steatosis in Non-Diabetic Obese Women. Nature Medicine, 24, 1070-1080. https://doi.org/10.1038/s41591-018-0061-3
|
[91]
|
Wang, R., Li, H., Yang, X., et al. (2018) Genetically Obese Human Gut Microbiota Induces Liver Steatosis in Germ-Free MiceFed on Normal Diet. Frontiers in Microbiology, 9, Article 1602.
https://doi.org/10.3389/fmicb.2018.01602
|
[92]
|
Del, C.F., Nobili, V., Vernocchi, P., et al. (2017) Gut Microbiota Profiling of Pediatric Nonalcoholic Fatty Liver Disease and Obesepatients Unveiled by an Integrated Meta-Omics-Based Approach. Hepa-tology, 65, 451-464.
https://doi.org/10.1002/hep.28572
|
[93]
|
Raman, M., Ahmed, I., Gillevet, P.M., et al. (2013) Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans with Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology and Hepatology, 11, 868-875.
https://doi.org/10.1016/j.cgh.2013.02.015
|
[94]
|
Zhu, L., Baker, S.S., Gill, C., et al. (2013) Characterization of Gut Micro-biomes in Nonalcoholic Steatohepatitis (NASH) Patients: A Connection between Endogenous Alcohol and NASH. Hepatology, 57, 601-609.
https://doi.org/10.1002/hep.26093
|
[95]
|
Aron-Wisnewsky, J., Vigliotti, C., Witjes, J., et al. (2020) Gut Microbiota and Hu-man NAFLD: Disentangling Microbial Signatures from Metabolic Disorders. Nature Reviews Gastroenterology & Hepatology, 17, 279-297.
https://doi.org/10.1038/s41575-020-0269-9
|
[96]
|
Mouzaki, M., Comelli, E.M., Arendt, B.M., et al. (2013) Intestinal Micro-biota in Patients with Nonalcoholic Fatty Liver Disease. Hepatology, 58, 120-127. https://doi.org/10.1002/hep.26319
|
[97]
|
Chassaing, B., Ley, R.E. and Gewirtz, A.T. (2014) Intestinal Epithelial Cell Toll-like Receptor 5 Regulates the Intestinal Microbiota to Prevent Low-Grade Inflammation and Metabolic Syndrome in Mice. Gastroen-terology, 147, 1363-1377. https://doi.org/10.1053/j.gastro.2014.08.033
|
[98]
|
Chu, H., Duan, Y., Yang, L. and Schnabl, B. (2019) Small Metabolites, Possible Big Changes: A Microbiota-Centered View of Non-Alcoholic Fatty Liver Disease. Gut, 68, 359-370. https://doi.org/10.1136/gutjnl-2018-316307
|
[99]
|
Zhao, Z., Wang, Z., Zhou, D., et al. (2021) Sodium Butyrate Supplementation Inhibits Hepatic Steatosis by Stimulating Liver Kinase B1 and Insulin-Induced Gene. Cellular and Molecular Gastroenterology and Hepatology, 12, 857-871.
https://doi.org/10.1016/j.jcmgh.2021.05.006
|
[100]
|
Dangana, E.O., Omolekulo, T.E., Areola, E.D., et al. (2020) Sodium Ac-etate Protects against Nicotine-Induced Excess Hepatic Lipid in Male Rats by Suppressing Xanthine Oxidase Activity. Chemi-co-Biological Interactions, 316, Article ID: 108929. https://doi.org/10.1016/j.cbi.2019.108929
|
[101]
|
Liu, L., Fu, C. and Li, F. (2019) Acetate Affects the Process of Lipid Metabolism in Rabbit Liver, Skeletal Muscleand Adipose Tissue. Animals, 9, Article 799. https://doi.org/10.3390/ani9100799
|
[102]
|
Li, Y., Xu, S., Mihaylova, M.M., et al. (2011) AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant Mice. Cell Metabo-lism, 13, 376-388.
https://doi.org/10.1016/j.cmet.2011.03.009
|
[103]
|
Skelly, A.N., Sato, Y., Kearney, S. and Honda, K. (2019) Mining the Mi-crobiota for Microbial and Metabolite-Based Immunotherapies. Nature Reviews Immunology, 19, 305-323. https://doi.org/10.1038/s41577-019-0144-5
|
[104]
|
Yao, H., Fan, C., Lu, Y., et al. (2020) Alteration of Gut Microbiota Af-fects Expression of Adiponectin and Resistin through Modifying DNA Methylation in High-Fat Diet-Induced Obese Mice. Genes & Nutrition, 15, Article No. 12.
https://doi.org/10.1186/s12263-020-00671-3
|
[105]
|
Ridaura, V.K., Faith, J.J., Rey, F.E., et al. (2013) Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice. Science, 341, 1069-1070. https://doi.org/10.1126/science.1241214
|
[106]
|
Zhao, S., Jang, C., Liu, J., et al. (2020) Dietary Fructose Feeds Hepatic Lipo-genesis via Microbiota-Derived Acetate. Nature, 579, 586-591. https://doi.org/10.1038/s41586-020-2101-7
|
[107]
|
Perry, R.J., Peng, L., Barry, N.A., et al. (2016) Acetate Mediates a Microbiome-Brain-β-Cell Axis to Promote Metabolic Syndrome. Nature, 534, 213-217. https://doi.org/10.1038/nature18309
|
[108]
|
Janeiro, M.H., Ramirez, M.J., Milagro, F.I., Martínez, J.A. and Solas, M. (2018) Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target. Nutrients, 10, Article 1398.
https://doi.org/10.3390/nu10101398
|
[109]
|
Barrea, L., Muscogiuri, G., Annunziata, G., et al. (2019) A New Light on Vitamin D in Obesity: A Novel Association with Trimethylamine-N-Oxide (TMAO). Nutrients, 11, Article 1310. https://doi.org/10.3390/nu11061310
|
[110]
|
Dehghan, P., Farhangi, M.A., Nikniaz, L., Nikniaz, Z. and Asghari-Jafarabadi, M. (2020) Gut Microbiota-Derived Metabolite Trimethylamine N-Oxide (TMAO) Potentially Increases the Risk of Obesity in Adults: An Exploratory Systematic Review and Dose-Response Meta- Analysis. Obesity Reviews, 21, e12993.
https://doi.org/10.1111/obr.12993
|
[111]
|
Schoeler, M. and Caesar, R. (2019) Dietary Lipids, Gut Microbiota and Lipid Me-tabolism. Reviews in Endocrine and Metabolic Disorders, 20, 461-472. https://doi.org/10.1007/s11154-019-09512-0
|
[112]
|
Gao, X., Liu, X., Xu, J., et al. (2014) Dietary Trimethylamine N-Oxide Exacerbates Impaired Glucose Tolerance in Mice Fed a High Fat Diet. Journal of Bioscience and Bioengineering, 118, 476-481.
https://doi.org/10.1016/j.jbiosc.2014.03.001
|
[113]
|
Koeth, R.A., Wang, Z., Levison, B.S., et al. (2013) Intestinal Microbiota Metabolism of L-Carnitine, a Nutrient in Red Meat, Promotes Atherosclerosis. Nature Medicine, 19, 576-585. https://doi.org/10.1038/nm.3145
|
[114]
|
Tan, X., Liu, Y., Long, J., et al. (2019) Trimethylamine N-Oxide Aggravates Liver Steatosis through Modulation of Bile Acid Metabolism and Inhibition of Farnesoid X Receptor Signaling in Nonalcoholic Fatty Liver Disease. Molecular Nutrition & Food Research, 63, e1900257. https://doi.org/10.1002/mnfr.201900257
|
[115]
|
Gottlieb, A. and Canbay, A. (2019) Why Bile Acids Are So Important in Non-Alcoholic Fatty Liver Disease (NAFLD) Progression. Cells, 8, Article No. 1358. https://doi.org/10.3390/cells8111358
|
[116]
|
Trabelsi, M.S., Daoudi, M., Prawitt, J., et al. (2015) Far-nesoid X Receptor Inhibits Glucagon-Like Peptide-1 Production by Enteroendocrine L Cells. Nature Communications, 6, Article No. 7629. https://doi.org/10.1038/ncomms8629
|